MYOSITIS
Clinical trials for MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new MYOSITIS trials appear
Sign up with your email to follow new studies for MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Year trial tests promising drug for debilitating muscle diseases
Disease control ENROLLING_BY_INVITATIONThis study follows up on previous participants to check the long-term safety and effectiveness of efgartigimod injections for inflammatory muscle diseases like dermatomyositis and polymyositis. About 240 adults who completed an earlier trial will receive the treatment for up to 5…
Matched conditions: MYOSITIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial aims to tame rare Muscle-Attacking disease
Disease control OngoingThis study is testing whether an experimental drug called nipocalimab can help control symptoms of active idiopathic inflammatory myopathies (IIM), a group of rare autoimmune diseases that cause muscle inflammation and weakness. About 36 adults with active IIM will receive either…
Matched conditions: MYOSITIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for rare muscle disease? experimental drug enters testing
Disease control OngoingThis study is testing a new drug called empasiprubart to see if it is safe and can help control the symptoms of dermatomyositis, a rare autoimmune disease that causes muscle weakness and skin rashes. About 3 adults with active dermatomyositis will receive either the new drug or a…
Matched conditions: MYOSITIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Early, aggressive treatment could halt debilitating muscle disease
Disease control OngoingThis study is testing if adding a treatment called intravenous immunoglobulin (IVIg) to standard steroid therapy early in the course of inflammatory muscle diseases (myositis) leads to better and faster improvement. It involves 44 adults newly diagnosed with conditions like derma…
Matched conditions: MYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Psoriasis pill tested for rare muscle disease
Disease control TerminatedThis study aimed to test if an oral medication called deucravacitinib, already approved for plaque psoriasis, could help adults with dermatomyositis or juvenile dermatomyositis who did not respond well to standard treatments. Participants would have taken the pill twice daily for…
Matched conditions: MYOSITIS
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Tracking High-Risk pregnancies to unlock better care for women with rare diseases
Knowledge-focused TerminatedThis study aimed to gather information about pregnancy in women with rare autoimmune diseases like lupus and rheumatoid arthritis. Researchers planned to follow these pregnancies to understand complications and how medications affect both mother and baby. The goal was to use this…
Matched conditions: MYOSITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC